Research Projects & Grants

For Profit Organization

  • Myozyme Temporary Access Program (MTAP). Protocol dated 25Jun2007. Informed consent version dated 23Apr2007. Investigator's Brochure Ed.6,May 22,2007., Role: PI, Genzyme Corporation, (08/2010 - 08/2011) Status: Completed
  • A two-week double-blind placebo-controlled crossover study to compare the efficacy and safety of a pregabalin/PF-00489791 combination versus pregabalin alone in patients with post-herpetic neuralgia. Protocol number: B0261002, version dated 15 October 2007. Molecular profiling supplement samples for Pfizer's exploratory research biobank, dated 11 October 2007. Informed consent version 1, dated 02/01/08. Genetics study informed consent version 1, dated 02/01/08. Investigator's brochure dated December 2007., Role: Investigator, Pfizer Pharmaceuticals, (06/2008 - 06/2009) Status: Completed
  • An open-label extension trial assessing the safety and tolerability of [S,S]-reboxetine in patients with postherpetic neuralgia (PHN). Protocol Number: A6061029, version date: 02 March 2006, Role: Investigator, Pfizer Pharmaceuticals, (08/2007 - 08/2008) Status: Completed
  • [S,S]-Reboxetin dose-range finding trial: a 16-week, randomized, double-blind, placebo and pregabalin controlled, multi-center trial of [S,S]-reboxetine in patients with postherpetic neuralgia (PHN). Protocol number: A6061026, version: 23 January 2006. Investigator's brochure dated February 2005., Role: Investigator, Pfizer Pharmaceuticals, (07/2006 - 07/2007) Status: Completed
  • The clomethizole acute stroke study in acute ischemic stroke (class-I): a double blind, parallel group, multinational, multicenter study of the efficacy and safety of i.v. clomethiazole compared to placebo in patients with acute ischemic stroke. Study code: SA-CMZ-0009 (Protocol dated 08/21/97 and Amendment No. 1 dated 06/23/98)., Role: Investigator, ASTRA (USA), (07/2000 - 07/2001) Status: Completed
  • Titration to response: Analysis of individualized therapy study (TRAITS) Protocol Capss -048, Role: Investigator, Ortho-McNeil Pharmaceutical, (06/1999 - 06/2000) Status: Completed
  • Open-label study to identify the reasons for TASMAR dosage regimen changes in fluctuating Parkinson's disease patients, with follow-up extension, Role: Investigator, Hoffmann-La Roche Inc., (08/1998 - 08/1999) Status: Completed

Internal

  • Clinical outcomes of patients who undergo electrodiagnostic testing for carpal tunnel syndrome, Role: Investigator, LLU Dept. of Neurology, (08/1999) Status: Completed